Titled AIDS Vaccines: ANOTHER Frontiers.

Kaiser Family Foundation. Copyright 2006 Advisory Panel Kaiser and Company Family members Foundation. All rights reserved.. AIDS Vaccines: ANOTHER Frontiers On Thursday released its annual report The AIDS Vaccine Advocacy Coalition, titled AIDS Vaccines: ANOTHER Frontiers, which says that without sufficient future planning, AIDS vaccine research could be slowed. The record – – which lists critical actions to ensure that goals in HIV/Helps prevention technologies, including AIDS vaccines, are met – – summarizes challenges and problems in developing HIV/AIDS prevention technologies.Today announced the commercial availability of Epoprostenol for Injection, a better formulation of epoprostenol that is stable at room temp, for the treating primary pulmonary hypertension and pulmonary hypertension connected with scleroderma spectral range of disease in NYHA Class III and Class IV patients. Simultaneously, the business has launched the chance registry, a multicenter, observational, U.S.-centered registry which will provide additional clinical experience on patients being treated with Epoprostenol for Injection.